Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

Lancet

Volumn 350, Issue 9081, 1997, Pages 829-833

  McDonagh, Theresa A ^a,c   Morrison, Caroline E ^b   Lawrence, Audrey ^a   Ford, Ian ^a   Tunstall Pedoe, Hugh ^b   McMurray, John J V ^a   Dargie, Henry J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SCREENING; SEX DIFFERENCE; SYMPTOM; SYSTOLE; URBAN AREA;

EID: 0030882421     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)03033-X     Document Type: Article

References (30)

1. Bonneaux L, Barendregt JJ, Meeter K, et al. Estimating clinical morbidity due to IHD and congestive heart failure: the future risk of heart failure. Am J Public Health 1994; 84: 20-28.
2. Gillum RF. Heart failure in the United States 1970-1985. Am Heart J 1987; 113: 1043-45.
3. Mc Murray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalisation for heart failure in Scotland. 1980-1990. Eur Heart J 1993; 14: 1158-62.
4. Ghjali JK, Cooper R, Ford E. Trends in hospitalisation rates for heart failure in the United States, 1973-1986. Arch Intern Med 1990; 150: 769-73.
5. Costanzo MR, Chair SA, Borge R, et al. Selection and treatment of candidates for heart transplantation. Circulation 1995; 92: 3593-612.
6. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure. N Engl J Med 1971; 285: 781-87.
7. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of congestive heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22 (suppl A): 6A-13A.
8. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
9. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure; results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 1987; 316: 1429-35.
10. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-91.
11. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of catopril on mortality in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327: 669-77.
12. Eriksson H, Svardsudd K, Larsson B, et al. Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J 1989; 10: 647-56.
13. Schocken D, Arrieta M, Leaverton P, Ross E. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992; 20: 301-06.
14. Wheeldon N, MacDonald T, Flucker CJ, McKendrick A, McDevitt D, Struthers AD. Echocardiography for chronic heart failure in the community. QJM 1993; 86: 17-24.
15. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arvelier D, Rajakangas A, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation 1994; 90: 583-612.
16. Smith WCS, Shwery MC, Tunstall-Pedoe H, Crombie IK, Tavendale R. Cardiovascular disease in Edinburgh and North Glasgow: a tale of two cities. J Clin Epidemiol 1990; 43: 637-43.
17. Schiller NB, Acquatella H, Ports TA, et al. Left ventricular volume from paired biplane ventriculography. Circulation 1979; 60: 547-55.
18. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of bronchitis in a working population. BMJ 1959; ii: 257-66.
19. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods, 2nd edn. Geneva: WHO. Monograph series, no 56.
20. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-51.
21. Mair FS, Crowley TS, Bundred PE. Prevalence, aetiology and management of heart failure in general practice. Br J Gen Pract 1996; 46: 77-79.
22. Gibson TC, White KL, Kleiner LM. The prevalence of congestive heart failure in two rural communities. J Chron Dis 1966; 19: 141-52.
23. Parameshwar J, Shackell MM. Richardson A Poole-Wilson PA, Sutton GC. Prevalence of heart failure in three general practices in North West London. Br J Gen Pract 1992; 42: 287-89.
24. Clarke KW, Gray D, Hampton JR. How common is heart failure? Evidence from PACT (Prescribing Analysis and Cost) data in Nottingham. J Public Health Med 1995; 17: 459-64.
25. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive cardiac failure in people without myocardial infarction. N Engl J Med 1997; 336: 1350-55.
26. Gardin JM, Siscovick D, AntonCulver H, et al. Sex, age and disease affect echocardiographic left ventricular mass and systolic function in the free-living elderly: the Cardiovascular Health study. Circulation 1995; 91: 1739-48.
27. Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham heart study). Am J Cardiol 1992; 70: 1180-84.
28. Teerlink JR, Goldhaber SZ, Pfeffer MA. An overview of contemporary etiologies of congestive heart failure. Am Heart J 1991; 121: 1852-53.
29. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-62.
30. Kostis JB. The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction. Am J Hypertens 1995; 8: 909-14.